Occupational Intakes of Radionuclides Part 1 - ICRP
Occupational Intakes of Radionuclides Part 1 - ICRP
Occupational Intakes of Radionuclides Part 1 - ICRP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
430<br />
431<br />
432<br />
433<br />
434<br />
435<br />
436<br />
437<br />
438<br />
439<br />
440<br />
441<br />
442<br />
443<br />
444<br />
445<br />
446<br />
447<br />
448<br />
449<br />
450<br />
451<br />
452<br />
453<br />
454<br />
455<br />
456<br />
457<br />
458<br />
459<br />
460<br />
461<br />
462<br />
463<br />
464<br />
465<br />
DRAFT REPORT FOR CONSULTATION<br />
Source Region (rs)<br />
Region <strong>of</strong> the body containing the radionuclide. The region may be an organ, a<br />
tissue, the contents <strong>of</strong> the alimentary tract or urinary bladder, or the surfaces <strong>of</strong><br />
tissues as in the skeleton and the respiratory tract.<br />
Spongiosa<br />
Term referring to the combined tissues <strong>of</strong> the bone trabeculae and marrow<br />
tissues (both active and inactive) located within cortical bone cortices across<br />
regions <strong>of</strong> the axial and appendicular skeleton. Spongiosa is one <strong>of</strong> three bone<br />
regions defined in the <strong>ICRP</strong> Publication 110 (<strong>ICRP</strong>, 2009) reference<br />
phantoms, the other two being cortical bone and medullary marrow <strong>of</strong> the long<br />
bone shafts. As the relative proportions <strong>of</strong> trabecular bone, active marrow, and<br />
inactive marrow vary with skeletal site, the homogeneous elemental<br />
composition and mass density <strong>of</strong> spongiosa is not constant but varies with<br />
skeletal site [see Annex B <strong>of</strong> <strong>ICRP</strong> Publication 110 (<strong>ICRP</strong>, 2009)].<br />
S-value (radiation-weighted) S w ( rT<br />
rS<br />
)<br />
The equivalent dose in target tissue or organ rT per nuclear transformation <strong>of</strong> a<br />
given radionuclide in source region rS, Sv (Bq s) -1 , for the Reference Adult<br />
Male and Reference Adult Female.<br />
ER,<br />
i YR<br />
, i (<br />
rT<br />
rS<br />
, ER,<br />
i )<br />
S w(<br />
rT<br />
rS<br />
) wR M ( r )<br />
R i T<br />
where:<br />
ER,i is the energy <strong>of</strong> the i th radiation <strong>of</strong> type R with the unit joule (J),<br />
YR,i is the yield <strong>of</strong> i th radiation <strong>of</strong> type R per nuclear transformation,<br />
(Bq s) -1 ,<br />
wR is the radiation weighting factor for radiation type R, Table 1,<br />
(rT←rS,ER,i) is the absorbed fraction,<br />
M(rT) is the mass <strong>of</strong> target tissue rT, kg.<br />
Target Tissue (rT)<br />
Tissue or organ <strong>of</strong> the body in which a radiation dose is received.<br />
Tissue weighting factor, wT. See also ‘Effective Dose’.<br />
The factor by which the equivalent dose in an organ or tissue T is weighted to<br />
represent the relative contribution <strong>of</strong> that organ or tissue to overall radiation<br />
detriment from stochastic effects (<strong>ICRP</strong>, 1991). It is defined such that<br />
w T 1<br />
T<br />
14